ACM
AERI

Aquatic Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Aquatic Capital Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$1K – 1684
2022
Q2 		$1K Sell
100
-100
-50% -$705 ﹤0.01% 1140
2022
Q1 		$2K Buy
+200
New +$1.54K ﹤0.01% 997

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aquatic Capital Management's AERI Position: Q3 2022 in Review

Aquatic Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 100 shares — an estimated $1K sold.

Aquatic Capital Management first reported a position in AERI in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Aquatic Capital Management reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 100 Aerie Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • Aquatic Capital Management first reported a position in Aerie Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Aquatic Capital Management's Aerie Pharmaceuticals position peaked at $2K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Aquatic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.